Cas:998-39-0 tributylgermane manufacturer & supplier

Chemical Name:tributylgermane

CAS.NO:998-39-0

Synonyms:MFCD00077987;Tri-n-butylgermanium hydride;Germane,tributyl;tributylgermanium hydride

Molecular Formula:C₁₂H₂₈Ge

Molecular Weight:244.99100

HS Code:2931900090

Physical and Chemical Properties:

Melting point:<0ºC

Boiling point:123 °C20 mm Hg(lit.)

Density:0.949 g/mL at 25 °C(lit.)

Index of Refraction:n20/D 1.45(lit.)

PSA:

Exact Mass:246.14000

LogP:4.99400

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like MFCD00077987 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tributylgermanium hydride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Germane,tributyl Use and application,tributylgermanium hydride technical grade,usp/ep/jp grade.

Related News: Government prosecutors often consider whether a corporation made a genuine effort to investigate and address potentially illegal activities once learning of them. tributylgermane manufacturer A number of UK citizens who failed to leave the coronavirus-struck Chinese city of Wuhan last week are now on a second flight to Europe, UK Foreign Secretary Dominic Raab said Sunday. tributylgermane supplier The company has now selected a single engineered iPSC clone, and generated and fully-characterized the master engineered iPSC bank for GMP production of FT819. tributylgermane vendor As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. tributylgermane factory As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment.